Development and outcomes of a psychiatric pharmacy clinic for indigent patients

American Journal of Health-System Pharmacy

Volumn 65, Issue 3, 2008, Pages 229-233

  Caballero, Joshua ^a   Souffrant, Garry ^b   Heffernan, Eileen ^b  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b Su Clinica Familiar   (United States)

Author keywords

Ambulatory care; Clinical pharmacists; Clinical pharmacy; Economics; Mental disorders; Pharmaceutical services; Sociology

Indexed keywords

AMFEBUTAMONE; DONEPEZIL; MEMANTINE; NICOTINE; SERTRALINE; TRAZODONE;

ADULT; AGED; ANXIETY; ARTICLE; BEDTIME DOSAGE; COGNITIVE DEFECT; CONSULTATION; COST CONTROL; DEPRESSION; DIARRHEA; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CENTER; HEALTH EDUCATION; HISPANIC; HUMAN; INDIGENT; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CARE; NAUSEA; PATIENT REFERRAL; PHARMACEUTICAL CARE; PHARMACIST; PHARMACY; PRIORITY JOURNAL; SMOKING CESSATION; ECONOMICS; MENTAL DISEASE; MENTAL HEALTH SERVICE; MIDDLE AGED; POVERTY; UNITED STATES;

COMMUNITY HEALTH CENTERS; COMMUNITY MENTAL HEALTH SERVICES; COMMUNITY PHARMACY SERVICES; COST SAVINGS; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PHARMACY; POVERTY; TEXAS;

EID: 38749101679     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp070266     Document Type: Article

References (20)

1. Mier N, Flores I, Robinson JR et al. Cultural, demographic, educational, and economic characteristics. In: Day RS, ed. Nourishing the future: the case for community-based nutrition research in the Lower Rio Grande Valley. Houston: Univ. of Texas School of Public Health; 2004.
2. U.S. Census Bureau. American fact finders; quick tables. http://factfinder.census. gov/home/saff/main.html?_lang=en (accessed 2007 Feb).
3. Lenze D. Local area personal income for 2002-2004. Surv Curr Bus. 2006; 5:28-53.
4. U.S. Department of Health and Human Services. Medically underserved area or population. http://bphc.hrsa.gov/bphc/ database.htm (accessed 2007 Feb).
5. Sanderson M, Brown S, McIntyre WJ. Health care resources and services. In: Day RS, ed. Nourishing the future: the case for community-based nutrition research in the Lower Rio Grande Valley. Houston: Univ. of Texas School of Public Health; 2004.
6. Warner DC, Jahnke LR. US/Mexico border health issues: the Texas Rio Grande Valley. San Antonio, TX: Univ. of Texas Health Science Center at San Antonio; 2003.
7. Finley PR, Crismon ML, Rush AJ. Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy. 2003; 23:1634-44.
8. Mendiondo MS, Ashford JW, Kryscio RJ et al. Modelling Mini Mental State Examination changes in Alzheimer's disease. Stat Med. 2000; 19:1607-16.
9. Dorevitch A, Perl E. The impact of clinical pharmacy intervention in a psychiatric hospital. J Clin Pharm Ther. 1996; 21:45-8.
10. Klopfer JD, Einarson TR. Acceptance of pharmacists' suggestions by prescribers: a literature review. Hosp Pharm. 1990; 25:830-2,834-6.
11. Alderman CP. A prospective analysis of clinical pharmacy interventions on an acute psychiatric inpatient unit. J Clin Pharm Ther. 1997; 22:27-31.
12. Canales PL, Dorson PG, Crismon ML. Outcomes assessment of clinical pharmacy services in a psychiatric inpatient setting. Am J Health-Syst Pharm. 2001; 58:1309-16.
13. Bond CA, Salinger RJ. Fluphenazine outpatient clinics: a pharmacist's role. J Clin Psychiatry. 1979; 40:501-3.
14. Lobeck F, Traxler WT, Bobinet DD. The cost-effectiveness of a clinical pharmacy service in an outpatient mental health clinic. Hosp Commun Psychiatry. 1989; 40:643-5.
15. Gray DR, Namikas EA, Sax MJ et al. Clinical pharmacists as allied health care providers to psychiatric patients. Contemp Pharm Pract. 1979; 2:108-16.
16. Rosen CE, Holmes S. Pharmacist's impact on chronic psychiatric outpatients in community mental health. Am J Hosp Pharm. 1978; 35:704-8.
17. Trivedi MH, Rush AJ, Wisniewski SR et al. Evaluation of outcomes with Citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006; 163:28-40.
18. Brawman-Mintzer O, Knapp RG, Rynn M et al. Sertraline treatment for generalized anxiety disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2006; 67:874-81.
19. Ellenor GL, Frisk PA. Pharmacist impact on drug use in an institution for the mentally retarded. Am J Hosp Pharm. 1977; 34:604-8.
20. Dole EJ, Murawski MM. Reimbursement for clinical services provided by pharmacists: what are we doing wrong? Am J Health-Syst Pharm. 2007; 64:104-6.